Sale!

GAD-65 Glutamic Acid Decarboxylase-65 IgG Test

Name: GAD-65 Glutamic Acid Decarboxylase-65 IgG Test
SKU: TEST-5342
Price: 1450 AED
Availability: InStock

Original price was: 1,610 د.إ.Current price is: 1,450 د.إ.

-10%

The GAD-65 (Glutamic Acid Decarboxylase-65) IgG Test is a specialized diagnostic procedure aimed at detecting antibodies against the enzyme glutamic acid decarboxylase (GAD) in the blood. GAD plays a crucial role in the synthesis of gamma-aminobutyric acid (GABA), a neurotransmitter involved in regulating nerve signals in the brain. The presence of GAD-65 antibodies is commonly associated with autoimmune disorders, including type 1 diabetes and certain neurological conditions such as Stiff Person Syndrome.

This test is particularly significant for individuals exhibiting symptoms suggestive of these autoimmune disorders or for those with a family history of type 1 diabetes, as it helps in the early detection and management of the condition. The test involves drawing a blood sample from the patient, which is then analyzed for the presence of GAD-65 IgG antibodies.

At DNA Labs UAE, the GAD-65 IgG Test is available for a cost of 1450 AED. The laboratory is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable test results. Patients opting for this test at DNA Labs UAE can expect a seamless experience, from sample collection to the delivery of results, all conducted with the highest standards of care and confidentiality.

Description

GAD-65 GLUTAMIC ACID DECARBOXYLASE- 65 IgG Test

Test Name: GAD-65 GLUTAMIC ACID DECARBOXYLASE- 65 IgG Test

Components: GAD-65 enzyme

Price: 1450.0 AED

Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery: Sample Wed / Sat by 9 am: Report Same day

Method: Enzyme Immunoassay

Test type: Diabetes

Doctor: Diabetologist, Physician

Test Department: DNA Labs UAE

Pre Test Information: No special preparation required

Test Details:

The GAD-65 (glutamic acid decarboxylase-65) IgG test is a blood test used to measure the levels of antibodies against the GAD-65 enzyme in the body. GAD-65 is an enzyme involved in the production of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain. This test is primarily used in the diagnosis of autoimmune conditions, particularly type 1 diabetes and certain neurological disorders such as stiff person syndrome and cerebellar ataxia. It helps to differentiate these conditions from other similar disorders.

Elevated levels of GAD-65 antibodies indicate an autoimmune response targeting GAD-65, suggesting the presence of an autoimmune disorder. However, it is important to note that the presence of these antibodies does not necessarily mean a person has an autoimmune disease, as low levels of antibodies can also be found in healthy individuals.

The GAD-65 IgG test is typically ordered when a person presents with symptoms that suggest an autoimmune or neurological disorder. It may be used in conjunction with other tests and clinical evaluations to help confirm a diagnosis.

It is important to consult with a healthcare provider for a proper interpretation of the test results and to discuss any concerns or symptoms you may be experiencing.

Test Name	GAD-65 GLUTAMIC ACID DECARBOXYLASE- 65 IgG Test
Components
Price	1450.0 AED
Sample Condition	2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery	SampleWed / Sat by 9 am: Report Same day
Method	Enzyme Immunoassay
Test type	Diabetes
Doctor	Diabetologist, Physician
Test Department:
Pre Test Information	No special preparation required
Test Details	The GAD-65 (glutamic acid decarboxylase-65) IgG test is a blood test used to measure the levels of antibodies against the GAD-65 enzyme in the body. GAD-65 is an enzyme involved in the production of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain. This test is primarily used in the diagnosis of autoimmune conditions, particularly type 1 diabetes and certain neurological disorders such as stiff person syndrome and cerebellar ataxia. It helps to differentiate these conditions from other similar disorders. Elevated levels of GAD-65 antibodies indicate an autoimmune response targeting GAD-65, suggesting the presence of an autoimmune disorder. However, it is important to note that the presence of these antibodies does not necessarily mean a person has an autoimmune disease, as low levels of antibodies can also be found in healthy individuals. The GAD-65 IgG test is typically ordered when a person presents with symptoms that suggest an autoimmune or neurological disorder. It may be used in conjunction with other tests and clinical evaluations to help confirm a diagnosis. It is important to consult with a healthcare provider for a proper interpretation of the test results and to discuss any concerns or symptoms you may be experiencing.